Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-27
Closed -$8.7K 276
2024
Q3
$8.7K Buy
+27
New +$8.83K ﹤0.01% 269
2023
Q4
Sell
-68
Closed -$18.3K 246
2023
Q3
$18.3K Buy
+68
New +$17K 0.01% 209
2020
Q3
Sell
-500
Closed -$118K 228
2020
Q2
$118K Hold
500
0.12% 108
2020
Q1
$101K Hold
500
0.11% 102
2019
Q4
$121K Buy
+500
New +$110K 0.1% 116

Other funds holding AMGN

Steph & Co's AMGN Position: Q4 2024 in Review

Steph & Co sold out of Amgen (AMGN) in Q4 2024, closing a stake of 27 shares — an estimated $8.7K sold.

Steph & Co first reported a position in AMGN in Q4 2019 and held it in 5 quarters. The position peaked at $121K in Q4 2019. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • Steph & Co reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
  • Steph & Co sold 27 Amgen shares in Q4 2024, an estimated $8.7K.
  • Steph & Co first reported a position in Amgen in Q4 2019 and held it in 5 quarters.
  • Steph & Co's Amgen position peaked at $121K in Q4 2019.
  • 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on Steph & Co's 13F filing for Q4 2024, filed 14 Jan 2025.